Cayman Chemical Off-Patent Drug Screening Library (96-Well)
The Cayman Chemical Off-Patent Drug Screening Library (96-Well) consists of eight plates and contains approximately 607 compounds in a 96-well Matrix tube rack format as 10 mM stock solutions in DMSO. Featuring a curated collection of FDA-approved compounds that are no longer covered under composition-of-matter patents in the United States, the library is intended for drug repurposing screening.
The library contains compounds from a variety of therapeutic areas, including oncology, gastroenterology, neurology, immunology, endocrinology, ophthalmology, pulmonology, infectious diseases and cardiology, among others. It is distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
Amsbio heparan sulfate monoclonal antibodies
Heparan sulfate antibodies from Amsbio are widely used by brain research groups around the world...
Dojindo Laboratories membrane protein detergents
Dojindo Laboratories' membrane protein detergents are designed to support the efficient...
Biosynth nucleosides, nucleotides and derivatives
Biosynth offers a comprehensive selection of nucleosides, nucleotides and nucleic acid...
